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Summary
Background and objectives: The World Health Organization (WHO) declared that
pandemic inﬂuenza A (H1N1) was a public health emergency of international concern
in April 2009. Herein, we describe the characteristics of patients in a Saudi Arabian
hospital with and without H1N1 infection.
Methods: We reviewed the records of patients admitted with inﬂuenza-like illness
and compared conﬁrmed pandemic H1N1 cases to the H1N1-negative patients admit-
ted to the hospital. Infections due to the novel H1N1 virus were conﬁrmed using
real-time reverse transcriptase polymerase chain reaction (rRT-PCR).
Results: During the study period, a total of 165 patients were admitted with
inﬂuenza-like illness and underwent rRT-PCR testing. Of these patients, 47 (28.4%)
had conﬁrmed novel H1N1 virus infection. Thus, the hospitalization incidence rate
was 13.4 cases per 100,000 persons. The remaining patients had negative H1N1 rRT-
PCR test results. The mean age± SD of the H1N1-positive patients was 30.3± 28.5
years compared with 25.3± 23 years for the H1N1-negative group (P = 0.28). Severe
obesity was observed in 6.7% and 8.5% of H1N1-positive and H1N1-negative patients,
respectively (P = 0.74). The clinical picture was similar between the two groups,
except for the higher prevalence of nausea (25.5% vs. 11%) and diarrhea (21.3% vs.
7.6%) in the H1N1-positive group than in the H1N1-negative group (P = 0.03) The
mortality rate was low in both groups.
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Conclusion: The clinical presentation and outcome are insufﬁcient to differentiate
between inﬂuenza-like illness (ILI) caused by H1N1 and that cause by other pathogens.
In general, both groups had mild disease in this cohort of patients in Saudi Arabia.
dulaziz University for Health Sciences. Published by Elsevier
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of 118 controls and 47 H1N1-positive patients, the
study had a power of 41% to detect a signiﬁcant dif-© 2011 King Saud Bin Ab
Ltd. All rights reserved.
ntroduction
novel inﬂuenza virus (H1N1) was initially recog-
ized to cause inﬂuenza-like illness in March 2009
n Mexico; subsequently, the H1N1 virus spread
orldwide. On June 11, 2009, the World Health
rganization (WHO) declared a phase 6 pandemic
f moderate severity [1]. The ﬁrst case of pan-
emic H1N1 infection in Saudi Arabia was reported
n June 3, 2009 [2]; subsequently, the infection
ecame widespread within the country. Three stud-
es of the outbreak were conducted in different
egions of Saudi Arabia. One study reported the
linical features of the ﬁrst 100 cases [3], and the
ther two studies addressed the clinical features
f hospitalized H1N1 patients [4,5]. This paper
eports the clinical characteristics of hospitalized
1N1-positive patients and compares these char-
cteristics with those of H1N1-negative patients. In
ddition, we aimed to determine if any speciﬁc dis-
ase characteristics could help distinguish between
andemic H1N1 and other causes of inﬂuenza-like
llness (ILI).
ethods
his was a prospective, observational study of
ll hospitalized patients admitted with ILI from
uly 18 to December 22, 2009. The Saudi Aramco
edical Services Organization (SAMSO) provides
edical care for Saudi Aramco employees and their
ependents. Approximately 370,000 individuals are
ligible for medical care at SAMSO. The main hos-
ital is a 380-bed referral institution, and the
ospital has ﬁve intensive care units (cardiac, med-
cal, surgical, pediatric, and neonatal). Admissions
o the hospital cover a whole range of patients
nd include general admissions, intensive care, and
atients receiving chemotherapy for hematological
nd solid organ malignancies. However, SAMSO does
ot provide solid organ or bone marrow transplant
ervices. On average, there are 36,426 admissions
nnually, with an average length of stay of 5.3 days.
During the initial phase of the H1N1 pandemic,
atients were screened for the presence of ILI.
atients requiring hospitalization with ILI were
f
w
w
(ested for the H1N1 virus based on recommen-
ations from the Centers for Disease Control and
revention (CDC) [6]. Patients were tested if they
eported fever (>38 ◦C) and at least two of the fol-
owing symptoms: cough, sore throat, headache,
yalgia, and rhinorrhea [3]. A nasopharyngeal (NP)
wab sample was obtained for real-time reverse
ranscriptase polymerase chain reaction (rRT-PCR)
esting.
All admitted patients with ILI during the
tudy period were reported to the epidemiol-
gy and infection control committee using a
tandardized form. The following data were col-
ected from the medical records: age, sex,
re-existing chronic conditions, body mass index
BMI), previous vaccination for 2009—2010 sea-
onal inﬂuenza, and presenting clinical symptoms
nd signs. Severe obesity was deﬁned as a BMI
f ≥35 and morbid obesity as a BMI of ≥40.
e also collected the following laboratory data:
BC, neutrophil and lymphocyte percentages.
dmission to the intensive care unit, mechani-
al ventilation and mortality were also recorded.
tatistical analyses were performed using SPSS,
nd descriptive statistics were used. Fisher’s exact
est was used to compare the two groups. A
wo-sided P value of <0.05 was considered signif-
cant.
esults
uring the study period from July 18 to December
2, 2009, a total of 165 patients were admitted
ith ILI and underwent rRT-PCR testing for the H1N1
nﬂuenza A virus. Of all the included patients, 118
71.6%) were negative for H1N1, and the remaining
7 (28.4%) were conﬁrmed to have a novel H1N1
irus infection. Thus, the hospitalization incidence
ate for H1N1-positive cases was 13.4 cases per
00,000 persons. Based on the small sample sizeerence. The weekly number of cases exhibited two
aves: weeks 3—6, from August 1 to August 28, and
eeks 13—20, from October 10 to December 4, 2009
Fig. 1). There was a signiﬁcant difference among
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Figure 1 Number of hospitalized cases during the study
period by presence or absence of 2009 H1N1 infection.
Figure 2 Percentage of H1N1-positive patients during
the summer, the fall and winter. P values are shown for
comparison.
Table 1 Demographic data of hospitalized patients
with and without 2009 H1N1 inﬂuenza virus infection.
H1N1-
negative
H1N1-
positive
P value
Number 118 47
Mean age± SD 30.3± 28.5 25.3± 23 0.286
Male:Female 63:55 24:23 0.86
Age group (years)
<1 9 (7.6) 3 (6.4) 0.956
1—9 37 (31.3) 13 (29.5) 0.844
10—19 14 (11.8) 9 (19.1) 0.223
11—29 8 (6.7) 6 (12.7) 0.349
30—39 2 (1.7) 2 (4.2) 0.686
40—49 13 (11) 4 (8.5) 0.846
50—59 9 (7.6) 5 (10.6) 0.752
a
p
pThe X-axis shows the weeks of the study, and the Y-axis
shows the number of cases.
seasons in the percentage of patients with H1N1
infection (Fig. 2). There were more H1N1-positive
patients in the fall than in the summer (P = 0.034)
and the winter (P = 0.024).
The mean age± SD of the H1N1-positive patients
was 30.3± 28.5 years compared to 25.3± 23 years
for the negative group (P = 0.28). The highest
percentage of cases was in the age group of
1—29 years (Table 1). This age group consti-
tuted 41.3% of the H1N1-positive patients and
49.8% of the H1N1-negative patients (P = 0.56).
Bronchial asthma was present in 23.4% of hospital-
ized patients with H1N1 infection compared with
19.5% among H1N1-negative patients (P = 0.67).
There was no difference between the groups in
terms of underlying medical conditions or previ-
ous vaccination with the seasonal inﬂuenza vaccine
(25.4% vs. 30.9%; P = 0.39) (Table 2). Severe obesity
(BMI of ≥35) was observed in 8 patients (6.7%) and
in 4 patients (8.5%) of the H1N1-positive and H1N1-
negative groups, respectively (P = 0.74). According
to the hospital protocol, all the patients admitted
with ILI during the study period, which coincided
with the H1N1 pandemic, received oseltamivir.
w
p
w
H
Table 2 Underlying conditions of hospitalized patients wit
H1N1-n
Asthma 23 (
Chronic obstructive pulmonary disease (COPD) 8 (
Coronary artery disease (CAD) 21 (
Diabetes mellitus (DM) 24 (
Sickle-cell disease (SCD) 10 (
Pregnancy 1 (
Severe obesity (BMI of ≥35) 8 (
Previous seasonal inﬂuenza vaccine 30 (60—69 11 (9.3) 2 (4.2) 0.441
>70 15 (12.7) 3 (6.4) 0.239
Of the 165 admitted patients, 41 (14.4%) were
dmitted to the intensive care unit, with equal
roportions of H1N1-positive and H1N1-negative
atients. One pregnant woman in each group
as admitted to the hospital during the study
eriod. The average lengths of hospital stay (ALOS)
ere 8.5 and 7.5 days for the H1N1-positive and
1N1-negative groups, respectively (P = 0.78). The
h and without 2009 H1N1 inﬂuenza virus infection.
egative; n (%) H1N1-positive; n (%) P value
19.5) 11 (23.4) 0.67
6.8) 3 (6.4) 0.61
17.8) 7 (14.9) 0.82
20.3) 9 (19.1) 1.0
8.5) 6 (12.8) 0.39
0.8) 1 (2.1) 0.49
6.7%) 4 (8.5%) 0.74
25.4) 15 (30.9) 0.39
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Table 3 Clinical features and laboratory data of hospitalized patients with and without 2009 H1N1 inﬂuenza virus
infection.
H1N1-negative (N = 118); n (%) H1N1-positive (N = 47); n (%) P value
Fever (≥38) 98 (83.1) 41 (87.2) 0.69
Sore throat 28 (23.7) 17 (36.2) 0.18
Nausea 13 (11) 12 (25.5) 0.02
Vomiting 22 (18) 15 (31.9) 0.07
Diarrhea 9 (7.6) 10 (21.3) 0.03
Headache 9 (7.6) 7 (14.9) 0.34
Cough 85 (72) 40 (85.1) 0.18
Rhinorrhea 34 (28.8) 16 (34) 0.76
Myalgia 25 (21.2) 10 (21.3) 0.72
WBC, mean± SD 10.8± 7.3 6.9± 4.5 0.008
Neutrophil %, mean± SD 58± 21 54± 19.3 0.26
Lymphocyte %, mean± SD 25± 17.5 29.5± 17 0.20
CXR done 113 (95.8) 45 (95.7) 0.79
Pneumonia on CXR 74 (62.7) 30 (63.8) 0.81
ICU admission 17 (14.4) 7 (14.5) 0.8
Intubation 8 (6.8) 4 (8.5) 0.74
Average length of stay (ALOS) 7.5± 14 8.2± 12.1 0.78
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linical picture was also similar between the two
roups, except patients with 2009 H1N1 were more
ikely to have nausea (25.5% vs. 11%; P = 0.019)
nd diarrhea (21.3% vs. 7.6%; P = 0.033) than
atients who tested as H1N1-negative (Table 3). In
ddition, the mean WBC count was higher in H1N1-
ositive patients (10.8) than in H1N1-negative
atients (6.9) (P = 0.008). One person in each group
ied. Secondary bacterial infections were docu-
ented in two patients in the H1N1-negative group
bacteremia) and in one H1N1-positive patient
nosocomial pneumonia).
iscussion
he current study showed that there were two
aves of hospitalization inﬂux, corresponding to
ugust 1 to August 28 and October 10 to December
, 2009. The ﬁrst case of pandemic H1N1 infec-
ion in Saudi Arabia was reported on June 3, 2009
2]. Thus, it took approximately two months for
he virus to cause a signiﬁcant number of hospital
dmissions. The waves of 2009-H1N1 infection and
he ﬁrst reported cases were observed in different
arts of the world. The Centers for Disease Control
CDC) reported the emergence of a novel inﬂuenza
(H1N1) virus in the United States on April 21,
009 [7]. There was a signiﬁcant difference in the
ercentage of patients with H1N1 infection during
ifferent seasons (Fig. 2). H1N1-positive patients
ere signiﬁcantly more common in the fall than in
he summer (P = 0.034) and the winter (P = 0.024).
r
i
t
d1 (2.1) 0.49
his difference is related to occurrence of the ﬁrst
ave of the disease in the summer followed by the
econd wave in the fall. Although it was expected
hat a third wave might occur in the winter, such
n event did not occur; the percentage of patients
n the winter was only 11%, compared with 27% in
he summer and 48% in the fall.
The mean age of the hospitalized patients was
0.3 years. In previous studies, the mean age of
he hospitalized patients positive for H1N1 infec-
ion was 25 years [5,8]. The hospitalized patients in
his study had a lower mean age than those reported
ecently by the Mayo Clinic [9]. In the current study,
he highest percentages of cases were in the age
roup of 1—29 years (41.3%). The ﬁnding is similar
o other published results showing that the highest
roportion of cases, both overall and among hospi-
alized patients, was among individuals aged 5—29
>60%) [4]. The differential age group involvement
ay be related to the fact that older persons have
re-existing immunity to the 2009 H1N1 virus. Alter-
ately, children and adolescents may have greater
ontact rates [10—12].
Most patients with pandemic H1N1 inﬂuenza
xperience mild disease; however, approximately
2% of those admitted to the hospital require
igh-dependency or intensive care [8]. The hospi-
alization rate was reported to be 26% in an earlier
tudy from Saudi Arabia [4]. The hospitalization
ate was 32—45% in those under the age of 18 years
n the United States [13,14]. The ICU admission in
his cohort of patients was 14.4%, which is in accor-
ance with the previously reported ICU admissions
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in the USA. In those studies, 9—31% of hospitalized
patients were admitted to ICUs [13—17]. In general,
the hospitalization rates may differ from country
to country due to differences in utilization of the
health care system and the timing of the study. Ear-
lier studies may have higher admission rates due
to the uncertainty of the disease at the start of
the pandemic [18]. Similar to a previous study per-
formed in Chile, a high proportion of patients were
admitted with pneumonia. In the current study, the
rate of pneumonia was 63.8%, compared with 75%
in that study [19].
Pregnant women accounted for 0.8% of the
admitted patients. Similarly, among 117 cases
of laboratory-conﬁrmed cases from Riyadh, one
patient (0.85%) was pregnant [4]. In contrast, in
published studies from other parts of the world,
pregnant women represented 7—10% of hospital-
ized patients and 6—9% of ICU patients [13,14].
Since the early phase of the 2009 H1N1 pandemic,
pregnancy was thought to be a risk factor for infec-
tion and poor outcome. However, the ﬁndings of
this study do not support this risk. A possible expla-
nation for the discrepancy between these studies
could be differences in the countries reporting
the data and in the patients included. In the cur-
rent study, we only included hospitalized patients,
which would be expected to result in a greater num-
ber of complications in pregnant women. Among
patients with severe or fatal cases of 2009 H1N1
virus infection, severe obesity (BMI≥ 35) or mor-
bid obesity (BMI≥ 40) has been reported at rates
that are higher—–by a factor of 5 to 15—–than the
rate in the general population [16,17,20]. However,
in the current study, the mortality rate was low
among both H1N1-positive and -negative patients.
The ALOS in our study was 7.5 days compared to
4.8 days in a previous study from Saudi Arabia [5]
and from the United Kingdom [8]. The difference
in the ALOS is probably related to the differences
in clinical protocol among the institutions. The
ALOS did not differ between H1N1-positive and
H1N1-negative patients in our study. The mortal-
ity rate of less than 1% in our study was similar
to that observed in previous studies from Saudi
Arabia. In a study from Saudi Arabia, 3 of 150
hospitalized patients (2%) died [5]. However, the
overall case fatality rate was less than 0.5%, with
a wide range of estimates (0.0004—1.47%) [21].
The fatality rate for symptomatic illness was esti-
mated to be 0.026—0.048% in the United States and
the United Kingdom [22—25]. This difference may
reﬂect uncertainty regarding case ascertainment
[24—26].
The clinical presentation of H1N1-positive
patients was similar to that of H1N1-negative
b
H
t
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atients apart from signiﬁcantly greater preva-
ences of nausea and diarrhea in the former group.
ecause the CDC ILI criteria were used to identify
atients for inclusion in the study, it was expected
hat there would be no differences between the
roups with respect to fever, sore throat, headache,
ough, rhinorrhea or myalgia. Thus, the fact that
here was no difference in cough between the
roups is expected. Our ﬁnding of more frequent
astrointestinal illness among patients with H1N1
choes ﬁndings from the United Kingdom, where
iarrhea was reported in 27% of H1N1-positive
atients [18]. It was also reported in the USA that
astrointestinal symptoms were more common with
1N1 than with seasonal inﬂuenza [10]. However,
his ﬁnding has been inconsistent, with no clear
xplanation proposed.
Anti-viral therapy was not used prior to presen-
ation of the included patients. Because the clinical
resentation of H1N1-positive and H1N1-negative
atients with ILI is similar, it is difﬁcult to diagnose
1N1 infection on clinical grounds. One method for
ifferentiation among the different viral causes of
LI is the Winthrop-University Hospital Infectious
isease Division’s diagnostic weighted point-score
ystem [27]. In that system, point scores were used
o make a probable diagnosis of H1N1 inﬂuenza
neumonia in admitted adults with ILI [27].
The limitations of this study are the inclusion of
nly admitted patients and the failure to include
ll patients with ILI. National policy restricts test-
ng to those with severe disease manifestations and
o admitted patients. Thus, the true number H1N1
ases and the incidence of H1N1 within the com-
unity were underestimated. Second, there was
o testing for seasonal inﬂuenza viruses; thus, no
rm conclusion can be made about the compari-
on between H1N1 and seasonal inﬂuenza patients.
hird, this study included the experience from a
ingle center with a relatively small number of
atients. Thus, the ﬁndings might not be general-
zable to all patients with H1N1 infection in Saudi
rabia. A fourth limitation of the study is that it
ncluded a small cohort; thus the study was unlikely
o detect small but potentially important differ-
nces between the groups. To have a power of 80%,
he study should have included a total of 510 cases
170 H1N1-positive cases and 340 H1N1-negative
ases).
In conclusion, we described the clinical presen-
ation and the outcomes of laboratory-conﬁrmed
ospitalized pandemic H1N1 cases from Saudi Ara-
ia. The comparison of admitted H1N1-positive and
1N1-negative patients with ILI showed that the
wo groups were similar except with respect to the
revalences of nausea and diarrhea and that the
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